Kyverna Therapeutics (KYTX) Change in Acquisitions & Divestments (2023 - 2026)

Kyverna Therapeutics has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $65.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 24.22% year-over-year to $65.7 million; the trailing twelve-month figure through Mar 2026 stood at $384.7 million (down 2.61% YoY), and the FY2025 full-year result was $405.7 million, up 22.46% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $65.7 million, down from $99.2 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $157.0 million in Q4 2024, with the low at $13.0 million in Q2 2024.
• Historically, Change in Acquisitions & Divestments has averaged $77.2 million across 4 years, with a median of $86.7 million in 2025.
• The largest YoY upside for Change in Acquisitions & Divestments was 854.62% in 2025 against a maximum downside of 36.81% in 2025.
• Kyverna Therapeutics' Change in Acquisitions & Divestments stood at $33.0 million in 2023, then jumped by 375.76% to $157.0 million in 2024, then plunged by 36.81% to $99.2 million in 2025, then slumped by 33.77% to $65.7 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $65.7 million (Q1 2026), $99.2 million (Q4 2025), and $95.7 million (Q3 2025), per Business Quant data.